A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma.

Benvinguts al Repositori Digital de la UPF



Consulteu el text complet

Cerca


Cerca avançada

Visualitza

El meu compte

Estadístiques